Airway remodelling in children with cystic fibrosis

Tom N Hilliard1, Nicolas Regamey, Janis K Shute

  • 1Department of Gene Therapy, National Heart and Lung Institute, Imperial College, London, UK. tom.hilliard@ubht.nhs.uk

Thorax
|May 29, 2007
PubMed

Insights

Early cystic fibrosis (CF) lung disease shows two airway remodeling types: inflammation-related matrix breakdown impacting lung function, and TGF-beta(1)-related reticular basement membrane thickening.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cystic Fibrosis Research

Background:

  • The interplay between airway structural changes and inflammation in early cystic fibrosis (CF) lung disease remains poorly understood.
  • This study investigated airway remodeling in children with CF compared to controls.

Purpose of the Study:

  • To determine the characteristics of airway remodeling in children with CF.
  • To compare airway structural changes in CF patients with those in primary ciliary dyskinesia (PCD) and chronic respiratory symptoms (CRS) groups.

Main Methods:

  • Cross-sectional study involving 43 children with CF, 7 with PCD, 26 with CRS, and 7 healthy controls.
  • Bronchoalveolar lavage (BAL) and endobronchial biopsy were performed.
  • Analysis included inflammatory cells, cytokines, proteases, matrix constituents in BAL fluid, and reticular basement membrane (RBM) thickness.

Main Results:

  • Elevated elastin, glycosaminoglycans, and collagen in BALF of CF patients correlated with age and inflammatory markers.
  • Matrix breakdown markers negatively correlated with pulmonary function (forced expiratory volume in 1s) in CF patients.
  • RBM thickness was significantly greater in CF patients and correlated with transforming growth factor-beta(1) (TGF-beta(1)).

Conclusions:

  • Two distinct airway remodeling patterns were identified in pediatric CF: matrix breakdown linked to inflammation and impaired lung function, and RBM thickening associated with TGF-beta(1).
  • RBM thickening appears independent of other inflammatory markers in early CF lung disease.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...